Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Braeburn Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11234
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Braeburn Inc (Braeburn), formerly Braeburn Pharmaceuticals Inc (Braeburn), is a biopharmaceutical company that develops medicines for the treatment of opioid addiction. The company’s lead product candidate CAM2038 is a weekly and monthly subcutaneous injection depot formulation of buprenorphine indicated for opioid use disorder (OUD). Braeburn harnesses FluidCrystal injection depot technology for developing its product portfolio. The company is funded by Wellington Management Company, Avista Capital Partners, New Leaf Venture Partners, Apple Tree Partners, Rock Springs Capital among others. Braeburn is headquartered in Plymouth Meeting, Pennsylvania, the US.

Braeburn Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9
Braeburn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Braeburn Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Venture Financing 13
Braeburn Pharma Raises USD110 Million in Mezzanine Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 15
Braeburn Pharma Raises USD22 Million in Venture Financing 16
Braeburn Pharma Raises USD35 Million in Venture Financing 17
Braeburn Pharma Raises USD15 Million in Venture Financing 18
Braeburn Pharma Raises USD30 Million in Venture Financing 19
Braeburn Pharma Raises USD23.8 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Braeburn Pharma Raises USD8.5 Million in Venture Financing 22
Braeburn Pharma Raises USD10 Million in Venture Financing 23
Licensing Agreements 24
Braeburn Pharma Enters into Licensing Agreement with Camurus 24
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 25
Camurus Expands Licensing Agreement with Braeburn Pharma 26
Braeburn Pharma Amends Licensing Agreement With Titan Pharma For Probuphine 28
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 30
Equity Offering 31
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Inc – Key Competitors 35
Braeburn Inc – Key Employees 36
Braeburn Inc – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Corporate Communications 38
Jun 25, 2018: Braeburn Names Richard Malamut As Chief Medical Officer 38
Dec 12, 2017: Braeburn Pharmaceuticals Welcomes Two New Members to its Board of Directors 39
Jun 05, 2017: Braeburn Pharmaceuticals Names Michael M. Derkacz as President and CEO 40
Other Significant Developments 41
Apr 12, 2018: Braeburn Launches Brave Action 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Braeburn Inc, Pharmaceuticals & Healthcare, Key Facts 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9
Braeburn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Braeburn Pharma Raises USD110 Million in Mezzanine Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 15
Braeburn Pharma Raises USD22 Million in Venture Financing 16
Braeburn Pharma Raises USD35 Million in Venture Financing 17
Braeburn Pharma Raises USD15 Million in Venture Financing 18
Braeburn Pharma Raises USD30 Million in Venture Financing 19
Braeburn Pharma Raises USD23.8 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Braeburn Pharma Raises USD8.5 Million in Venture Financing 22
Braeburn Pharma Raises USD10 Million in Venture Financing 23
Braeburn Pharma Enters into Licensing Agreement with Camurus 24
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 25
Camurus Expands Licensing Agreement with Braeburn Pharma 26
Braeburn Pharma Amends Licensing Agreement With Titan Pharma For Probuphine 28
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 30
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Inc, Key Competitors 35
Braeburn Inc, Key Employees 36

List of Figures
Braeburn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rongsheng Petrochemical Co Ltd (002493):企業の財務・戦略的SWOT分析
    Summary Rongsheng Petrochemical Co Ltd (Rongsheng), a subsidiary of Zhejiang Rongsheng Holding Group Co Ltd is a chemical company that produces and distributes PTA, polyester fiber and chemical products. The company’s products include synthetic fibers and films, synthetic raw material, synthetic res …
  • Navamedic ASA (NAVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. …
  • Orpak Systems Limited:企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nordic American Tankers Limited (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • OmniComm Systems Inc (OMCM)-医療機器分野:企業M&A・提携分析
    Summary OmniComm Systems Inc (OmniComm) is a web-based electronic data capture and eClinical software and services providing company. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative si …
  • Corbion NV (CRBN):企業の財務・戦略的SWOT分析
    Corbion NV (CRBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Genae Associates NV:医療機器:M&Aディール及び事業提携情報
    Summary Genae Associates NV (Genae Group) is a medical device CRO that offers clinical trial management services. The organization develops and commercializes investigational products and therapies that advance practices in medicine. Its services comprise clinical trial management, regulatory and sa …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Metrion Biosciences Ltd (Metrion Biosciences) is a contract research organization that offers ion channel drug discovery services. The organization offers cardiac safety screening services, neuroscience-related assays and platforms and translational assays. Its ion channel screening services …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • University of New Mexico-製薬・医療分野:企業M&A・提携分析
    Summary University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin America …
  • Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析
    Summary Pfizer Ltd India (Pfizer India) a subsidiary of Pfizer Inc, operates as a pharmaceutical company that develops medicines for brain disorders. The company’s products portfolio comprises of anti-allergics, anti-diabetics, anti-histamines, anti-infectives, anti-parasitics, drugs for cardiovascu …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • OPTIMA packaging group GmbH:戦略・SWOT・企業財務分析
    OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report Summary OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pick N Pay Stores Limited:企業の戦略・SWOT・財務分析
    Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Prothena Corp Plc (PRTA)-医療機器分野:企業M&A・提携分析
    Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing protein …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆